Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Kirman

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Regulatory Toxicology and Pharmacology : RTP|March 4, 2014
Evaluation of urinary speciated arsenic in NHANES: issues in interpretation in the context of potential inorganic arsenic exposureLesa L Aylward, Santhini Ramasamy, Sean M Hays, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 25, 2009
Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokineticsTed Simon, Lesa L Aylward, Christopher R Kirman, et al.
Journal of Toxicology and Environmental Health. Part A|January 11, 2003
A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the ratChristopher R Kirman, Michael L Gargas, Randy Deskin, et al.
Environmental Health Perspectives|December 13, 2012
Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicalsLesa L Aylward, Christopher R Kirman, Rita Schoeny, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|January 7, 2014
Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogensRichard A Becker, Sean M Hays, Christopher R Kirman, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 2, 2009
Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humansLisa M Sweeney, Christopher R Kirman, Michael L Gargas, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 2, 2009
Estimation of safe dietary intake levels of acrylamide for humansRobert G Tardiff, Michael L Gargas, Christopher R Kirman, et al.
Regulatory Toxicology and Pharmacology : RTP|April 7, 2011
Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99)Kannan Krishnan, Therese Adamou, Lesa L Aylward, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
Monitored and Modeled Ambient Air Concentrations of Ethylene Oxide: Contextualizing Health Risk for Potentially Exposed Populations in GeorgiaRyan C Lewis, Patrick J Sheehan, Christopher G DesAutels, et al.
Journal of Exposure Science & Environmental Epidemiology|October 13, 2011
Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteriaChristopher R Kirman, Lesa L Aylward, Ben C Blount, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Regulatory Toxicology and Pharmacology : RTP|March 4, 2014
Evaluation of urinary speciated arsenic in NHANES: issues in interpretation in the context of potential inorganic arsenic exposureLesa L Aylward, Santhini Ramasamy, Sean M Hays, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 25, 2009
Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokineticsTed Simon, Lesa L Aylward, Christopher R Kirman, et al.
Journal of Toxicology and Environmental Health. Part A|January 11, 2003
A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the ratChristopher R Kirman, Michael L Gargas, Randy Deskin, et al.
Environmental Health Perspectives|December 13, 2012
Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicalsLesa L Aylward, Christopher R Kirman, Rita Schoeny, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|January 7, 2014
Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogensRichard A Becker, Sean M Hays, Christopher R Kirman, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 2, 2009
Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humansLisa M Sweeney, Christopher R Kirman, Michael L Gargas, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 2, 2009
Estimation of safe dietary intake levels of acrylamide for humansRobert G Tardiff, Michael L Gargas, Christopher R Kirman, et al.
Regulatory Toxicology and Pharmacology : RTP|April 7, 2011
Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99)Kannan Krishnan, Therese Adamou, Lesa L Aylward, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
Monitored and Modeled Ambient Air Concentrations of Ethylene Oxide: Contextualizing Health Risk for Potentially Exposed Populations in GeorgiaRyan C Lewis, Patrick J Sheehan, Christopher G DesAutels, et al.
Journal of Exposure Science & Environmental Epidemiology|October 13, 2011
Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteriaChristopher R Kirman, Lesa L Aylward, Ben C Blount, et al.
Pageof 6